Analyst Ratings for Karuna Therapeutics
Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter:
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
HISTORICAL FACTS: Karuna rapeutics - Caught on Camera
Analyst Ratings for Karuna Therapeutics
Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings within the last quarter:
Benzinga ·
Karuna Therapeutics: Q1 Earnings Insights
Karuna Therapeutics (NASDAQ:KRTX) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Organisations
Nasdaq
22,819 stories
NYSE
19,906 stories
Morgan Stanley
2,057 stories
Barclays
1,847 stories
Deutsche Bank
629 stories
Advanced Micro Devices
571 stories
Piper Sandler
428 stories
Snowflake
393 stories
BRC
296 stories
APA
290 stories
Dell Technologies
224 stories
Five Below
144 stories
Baker Hughes
141 stories
BMO Capital
132 stories
Coinbase Global
125 stories
Canaccord Genuity
87 stories
Cameco
83 stories
FMC
74 stories
Warby Parker
68 stories
Motorsport Games
61 stories
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
